Le Lézard
Classified in: Health
Subject: FDA

Additive Orthopaedics Announces FDA Clearance of their Minimally-Invasive, Intramedullary 3D Printed Bunion Correction System for the Extremities Market


LITTLE SILVER, N.J., June 21, 2017 /PRNewswire/ -- Additive Orthopaedics, LLC., an orthopaedic device company, today announced that is has received FDA 510(k) clearance for its 3D printed minimally-invasive, intramedullary Bunion Correction System, to address alignment and stabilization of bunions. 

Additive Orthopaedics Logo

According to Dr. Selene Parekh, Professor of Surgery in the Department of Orthopaedic Surgery at Duke Orthopaedics and North Carolina Orthopaedic Clinic, "This new 3D printed implant allows us to have features in plates that we cannot get with standard manufacturing processes. Namely, it allows an area of the plate to provide additional fixation and strength over time enabling bone to grow onto and through the plate. The hope is that a feature like this will allow for more reliable integration and alignment of bones following a bunion procedure." 

This is the Company's fourth 510(k) clearance leveraging additive manufacturing and 6th complete product line, which includes their 3D printed core products, biologics, and customs for limb salvage and complex revision cases.  Surgeons have implanted over 400 of their individual devices since the first full commercial product launch at the end of 2016.  The Company has recently closed a Series A Round of $1M.  

About Additive Orthopaedics, LLC.

Additive Orthopaedics is an early stage orthopaedic company focused on the integration of advanced manufacturing and biologics for the benefit of a better patient outcome. 

Contact:
Greg Kowalczyk
732.882.6633
[email protected]

SOURCE Additive Orthopaedics, LLC.


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: